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ABSTRACT: Background. The purpose of this study was to examine
associations of pretreatment serum carotenoids, tocopherols, and quer-
cetin with prognosis in 154 patients newly diagnosed with head and
neck cancer.
Methods. Pretreatment blood and health surveys were collected. Serum
micronutrients were measured by high performance liquid chromatogra-
phy. Data on recurrence and death were collected annually. Cox propor-
tional hazards models measured associations of serum nutrient
concentrations with recurrence and overall survival.
Results. During a median follow-up time of 37 months, there were 32
recurrences and 27 deaths. After controlling for covariates, subjects with
high versus low serum xanthophyll and total carotenoid concentrations
had significantly longer recurrence-free time (p 5 .002 and p 5 .02,
respectively). Overall survival time was significantly longer in patients
with high versus low serum xanthophyll concentrations (p 5 .02).
Conclusion. Future research should evaluate the possible benefits of
interventions to increase intakes of rich food sources of xanthophylls in
this patient population. VC 2015 Wiley Periodicals, Inc. Head Neck 38:
E1591–E1597, 2016
KEY WORDS: serum micronutrients, xanthophylls, quercetin, head
and neck cancer, recurrence, survival
INTRODUCTION
Higher fruit and vegetable intake is associated with
decreased risk of head and neck cancer development and
mortality.1–6 We recently reported that a whole foods pat-
tern, characterized by high intakes of vegetables, fruits,
whole grains, poultry, and fish, was associated with lower
recurrence and mortality rates in a prospective cohort of
patients newly diagnosed with head and neck cancer.7
This same dietary pattern was associated with lower lev-
els of proinflammatory cytokines that have been hypothe-
sized to facilitate tumor growth and dissemination in
patients with head and neck cancer.8
Although our previous work provides evidence that
consuming a healthy diet before head and neck cancer
treatment is beneficial to clinical and biological head and
neck cancer outcomes, a limitation of these studies was
the use of a self-reported diet via food frequency ques-
tionnaire, which is susceptible to measurement error.
Examining biomarkers of dietary intake in relation to
head and neck cancer disease outcomes is important, as
consistency across results will reduce the likelihood that
bias or confounding was responsible for previously
observed associations with the reported diet.9
Blood carotenoids have been established as valid bio-
markers of fruit and vegetable intake.10 Tocopherols are
found mainly in vegetable oils and high fat foods like
nuts. The roles of carotenoids and tocopherols in cancer
chemoprevention have been of great interest over the past
2 decades because of their antioxidant properties.11 Quer-
cetin is a flavonol that accounts for about 75% of typical
U.S. intake of flavonoids.12 It is widely distributed in
many fruits and vegetables; tea, onions, allium vegetables,
and apples with skin are major food sources of quercetin
in the United States, and these foods are low in the highly
pigmented carotenoids.12–15 Dietary intake of b-carotene
and quercetin have been reported to be moderately corre-
lated (r 5 0.27 and r 5 0.32 for women and men, respec-
tively),12 suggesting measurement of quercetin may
capture fruit and vegetable intakes that are not well
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represented by carotenoids.16 Like carotenoids and toco-
pherols, quercetin has a potential role in cancer preven-
tion17,18 because of its anti-inflammatory effects and
promotion of apoptosis and autophagy in cancer
cells.19–23 Few studies have examined associations of
serum carotenoids and tocopherols with head and neck
cancer outcomes,3,6,24 and quercetin concentrations have
never been reported in relation to head and neck cancer
mortality.
This study evaluated the associations of pretreatment
serum carotenoids, tocopherols, and quercetin with
recurrence-free and overall survival time in a cohort of
patients newly diagnosed with head and neck cancer. The
hypothesis was that a protective relationship would be




This prospective cohort study utilized data collected
from 154 patients newly diagnosed with head and neck
cancer enrolled in the University of Michigan Head and
Neck Specialized Program of Research Excellence (HN-
SPORE). All study activities were approved by the inter-
nal Institutional Review Board at the University of
Michigan and study participants gave signed, informed
consent to participate. Recruitment and data collection
methods have been described elsewhere.8 Briefly, subjects
were recruited between November 2008 and August
2012. Exclusion criteria included being <18 years of age,
pregnant, non-English speaking, diagnosed as mentally
unstable (eg, presence of schizophrenia, severe, unman-
aged depression, or any other state or condition that study
personnel feel would make active study participation dif-
ficult or impossible), diagnosed with another non-upper
aerodigestive tract cancer, or diagnosed with any other
head and neck primary within the past 5 years.
Enrolled participants completed a self-administered epi-
demiologic health questionnaire before treatment that col-
lected data on demographics, tobacco use, alcohol
consumption, weight status, and comorbidities, as well as
a food frequency questionnaire.9 Clinical data were
recorded from the medical records. Pretreatment periph-
eral blood samples (30 mL) were collected using routine
venipuncture. Sera were collected after centrifugation of
blood and stored in the HN-SPORE Tissue Core in
0.5 mL aliquots at 2808C until testing. All serum sam-
ples were barcoded and analyzed blinded to subject iden-
tifiers or outcomes.
During the study period, a total of 520 evaluable sub-
jects were recruited, yielding a 92% participation rate.
For the current analysis, we analyzed serum nutrient val-
ues for those subjects for whom pretreatment serum sam-
ples, epidemiologic health questionnaires, and food
frequency questionnaires were available. Two hundred
nineteen subjects (42.1%) completed baseline health ques-
tionnaires and food frequency questionnaires with valid
data. Food frequency questionnaire data were considered
valid according to standard criteria (ie, no complete pages
missing, no more than 70 missing items, and total energy
intake 5000 kcals/day and 200 kcals per day).9 Sixty-
five subjects did not have baseline blood collected or
adequate samples available for measurement, leaving a
final sample size of 154.
Measures
Predictors — serum micronutrients, chemicals, and instrumenta-
tion. Quercetin, morin, citric acid, ammonium acetate,
hydrochloric acid, and enzymes were obtained from
Sigma Aldrich (St. Louis, MO). High performance liquid
chromatography grade hexane, acetonitrile, water, methyl
tert-butyl ether and methanol were Burdick and Jackson
brand, high performance liquid chromatography-grade
(Honeywell, Morristown, NJ). Tocol was a gift of Hoff-
man La Roche (Basel, Switzerland). High performance
liquid chromatography was performed using a Shimadzu
system consisting of 2 LC-20AT pumps, a CTO-20A
autosampler, a CBM-20A controller, and 2 detectors in
tandem: SPD-20AV UV/visible detector and a 5600A
ESA CoulArray Multi-Electrode Detector (ESA Bioscien-
ces, Chelmsford, MA). Chromatograms were analyzed
using ESA CoulArray Software (1.1.2.0, 2002).
Analysis of serum carotenoids, tocopherols, and quercetin. Anal-
ysis of serum carotenoids and tocopherols has been
described elsewhere.8 For quercetin, serum aliquots, 200
mL, were buffered with 21 mL 0.55 M sodium acetate
buffer (pH 5.0) followed by addition of 800 units b-
glucuronidase from Helix pomatia, that contains sulfatase
activity, and incubated at 378C for 17 hours to release
conjugates, based on the methods of Erlund et al.25 The
internal standard morin, 10 mL of 10 mg/mL in methanol,
was then added along with 0.1 M hydrochloric acid (25
mL) followed by vortexing. Extraction with ethyl acetate
(500 mL) was performed twice. The organic extracts were
dried in the SpeedVac and reconstituted in 100 mL of
high performance liquid chromatography mobile phases A
and B mixed in a 1:1 ratio before high performance liquid
chromatography analysis. Detection was with the ESA
detector set at 50 mV, 100 mV, and 150 mV.
The separations were performed with a reversed phased
YMC-Pack Pro C18 column (150 3 4.6 mm, catalog
#AS12SO3–1546WT; YMC, Allentown, PA). The mobile
phases used were: (A) 10% acetonitrile, 80% water, and
10% buffer (250 mM ammonium acetate, 750 mM citric
acid, and pH 2.7), and (B) 50% acetonitrile, 40% water,
and 10% buffer. The gradient began at 40% B and then
increased to 100% B over 9 minutes. There was a 3-
minute final hold, and then a 5-minute re-equilibration
period. The flow rate was 1.0 mL/min. The serum sam-
ples were analyzed in 6 batches, and aliquots of the same
standards were used for calibration with each batch. The
inter-day coefficients of variation for the individual caro-
tenoids were between 3% and 11%. Our laboratory par-
ticipated in the National Institutes of Standards
Technology Round Robin for carotenoids, and the values
obtained by our laboratory were within 2 SDs for all the
samples analyzed.
Covariates
Sociodemographic variables included age and sex.
Tobacco and alcohol use data were categorized as current,
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former, or never, whereas “current” reflected use in the 12
months before cancer diagnosis. Body mass index (BMI)
(kg/m2) was calculated at diagnosis based on self-reported
weight and height. Comorbidities were recorded using the
Adult Comorbidity Evaluation-27 and categorized into
none, mild, moderate, or severe comorbidities.26 As previ-
ously described, tumor human papillomavirus (HPV) status
was determined by an ultrasensitive method using real-
time competitive polymerase chain reaction and matrix-
assisted laser desorption/ionization time of flight mass
spectroscopy with separation of products on a matrix
loaded silicon chip array.27 As a result of having equivocal
HPV status data for 34 participants (22.1%), tumor site
was recorded from the medical records and categorized
into 4 groups, which allowed for consideration of known
HPV status: (1) oral cavity; (2) oropharyngeal HPV-
positive; (3) oropharyngeal HPV-negative or unknown; and
(4) larynx. To increase statistical power, cancer stage was
categorized a priori into 2 groups, with stages 1 and 2 col-
lapsed, and stages 3 and 4 collapsed to increase statistical
power. The method used to determine HPV status has been
previously described.8,27
Outcomes: Recurrence and survival
Patients were followed according to National Compre-
hensive Cancer Network guideline intervals. New tumor
events and status (recurrence, residual disease, persistent
disease, and second primary) were updated at each visit
and annually via medical record review. For subjects who
did not return to our institution for surveillance after their
treatment, information on tumor events and status was
obtained through self-report and contact with local physi-
cians. Deaths were confirmed through the Social Security
Death Index, yearly survey updates, notification from
family, and medical record reviews. Survival time was
censored to February 1, 2014. Recurrence events were
censored to the last date of each subject’s annual medical
record review. Persistent disease was assigned a follow-
up time of 1 day for calculation of time to recurrence.
Subjects were considered to be lost to follow-up if they
had not returned for care, and there was a failure to con-
tact the subject or to collect updates when contacting the
referring physician. Subjects lost to follow-up were cen-
sored until their last known status.
Statistical analyses
Descriptive statistics (means and frequencies) were gen-
erated for demographic, epidemiologic, and clinical varia-
bles. To assess relationships between serum nutrient
concentrations (categorized into tertiles) and demo-
graphic, clinical, and behavioral variables, chi-square tests
were used for categorical variables and Wilcoxon rank-
sum tests were used for continuous variables. To examine
whether degradation of serum nutrient concentrations may
have occurred over time, Spearman correlations were
computed between sample storage time (number of days
between date of assay and date blood samples were col-
lected) and serum nutrient concentrations.
Cox proportional hazards regression models were used
to estimate hazard ratios (HRs) and 95% confidence inter-
vals (CIs) for the associations of recurrence-free and
overall survival time with serum nutrient concentrations.
To arrive at a parsimonious final multivariable model,
variables were considered for inclusion using a backward
selection strategy based on a priori knowledge and input
from treating physicians of this study population. Final
multivariable models were adjusted for age, BMI, tumor
site, cancer stage, and tobacco use. Sex, alcohol use,
comorbidities, and sample storage time were considered
as covariates but excluded from final models as they did
not substantially alter parameter estimates. Treatment
modality was not considered as a covariate in this analy-
sis because of the high collinearity of treatment and dis-
ease site (p< .001 for chi-square test with the p value
approximated by Monte–Carlo simulation). Other behav-
ioral variables (eg, physical activity and red meat intake)
were not considered as covariates based on previous find-
ings that showed a lack of association of these variables
with mortality in this study population.1,7 All serum nutri-
ent concentrations were categorized into tertiles (low,
medium, and high concentrations) for use in models and
display in Kaplan–Meier plots. HRs and 95% CIs were
TABLE 1. Pretreatment characteristics of patients newly diagnosed with




Age, y 59 (11); range,
25–93
Female 33 (21)
Non-Hispanic white 147 (95.4)
Death events 27 (17.5)
Recurrence events 32 (27.8)
BMI, kg/m2 27.5 (6.2); range,
13.0–54.3
Underweight, <18.5 6 (4)
Normal, 18.5–24.9 45 (29)
Overweight, 25–29.9 66 (43)
Obese, 301 37 (24)
Tobacco status
Never 30 (19)
Current, within 12 mo 57 (37)
Former, quit >12 mo 67 (44)
Alcohol status
Never 7 (5)
Current, within 12 mo 110 (71)
Former, quit >12 mo 37 (24)
Disease site
Oral cavity 52 (34)
Oropharynx HPV-positive 46 (30)




Stage IV 102 (66)
Stage III 26 (17)
Stage II 13 (8)






Abbreviations: BMI, body mass index; HPV, human papillomavirus.
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estimated for each tertile of serum nutrient concentration
and compared with the lowest, tertile 1. The SAS system
version 9.4 (SAS Institute, Cary, NC) was used for all
analyses. The p values of .05 or less were considered stat-
istically significant and no multiplicity adjustments were
performed.
RESULTS
During a median longitudinal follow-up time of 37
months, there were 32 (20.8%) recurrence events and 27
deaths (17.5%). Epidemiological characteristics of the
study population are given in Table 1. The mean age of
study participants was 59 years. The majority of partici-
pants were men (79%). The mean BMI at diagnosis was
27.2 kg/m2, with 67% of the population considered over-
weight or obese. Only 19% of the participants reported
never smoking, whereas 37% reported smoking in the last
12 months. Tumors were most commonly of the oral cav-
ity (37%) or HPV-positive oropharynx (30%) and diag-
nosed at an advanced stage (66% stage IV).
Select patient characteristics across tertiles of serum
total carotenoids, xanthophylls, quercetin, a-tocopherol,
and g-tocopherol are shown in Table 2. Age was posi-
tively associated with tocopherols. Mean BMI increased
significantly across increasing tertiles of quercetin. A sig-
nificantly higher proportion of patients with stage III or
IV cancers had low serum xanthophyll concentrations.
Participants with the highest serum xanthophyll and total
carotenoid concentrations were significantly less likely to
be current smokers. Patients self-reporting higher intake
of leafy green vegetables, dark yellow and orange vegeta-
bles, and fruit on the food frequency questionnaire had
significantly higher serum xanthophyll concentrations.
Serum total carotenoid concentrations were significantly
positively associated with intake of dark yellow and
orange vegetables and fruit on the food frequency ques-
tionnaire. We previously reported serum total carotenoids,
a-carotene, b-carotene, b-cryptoxanthin, lutein, zeaxan-
thin, and a-tocopherol to be significantly correlated with
reported dietary intake of each micronutrient in this study
population.8 Significant, negative Spearman correlations
were found between sample days and b-carotene
(q 5 20.29; p 5 .001), a-carotene (q 5 20.28; p 5 .001),
and total carotenoids (q 5 20.22; p 5 .01).
Kaplan–Meier curves and associated p values for the
associations between each serum nutrient (categorized
into tertiles) with time-to-recurrence and time-to-death
(any cause) are shown in Figure 1. HRs and 95% CIs for
recurrence and mortality by serum micronutrient levels
are shown in Table 3. After controlling for covariates,
participants with high serum xanthophylls and total caro-
tenoids were significantly less likely to experience a
recurrence than those with low concentrations. Partici-
pants with high serum xanthophylls also had significantly
lower mortality than those with low concentrations.
Although not statistically significant, there seemed to be
trends toward lower recurrence with higher serum
b-carotene, lycopene, and a-tocopherol levels, and lower
mortality with high serum g-tocopherol levels. There
were no apparent associations between recurrence and a-
carotene, quercetin, and g-tocopherol, or between mortal-
ity and a-carotene, b-carotene, lycopene, total carote-
noids, quercetin, and a-tocopherol.
DISCUSSION
This study of pretreatment serum micronutrient concen-
trations in patients newly diagnosed with head and neck
cancer showed that high pretreatment serum xanthophyll
concentrations were associated with a lower risk of recur-
rence and mortality, independent of other factors known
to influence these outcomes. Results also showed that
high pretreatment total carotenoid concentrations were
associated with decreased risk of recurrence. The results
of this study are of particular importance because they
are consistent with the previous findings of our group that
a whole foods dietary pattern, derived from principal
components analysis, was associated with lower risk of
head and neck cancer mortality and recurrence.7 Foods
that were among the most significant contributors to this
dietary pattern (ie, had the highest factor loadings)
TABLE 2. Patient characteristics of subjects by serum nutrient levels (n 5 154).*
Total carotenoids Total xanthophylls Quercetin
a-Tocopherols and
g-tocopherols
Characteristic Low Medium High Low Medium High Low Medium High Low Medium High
Median concentration, lg/dL 0.13 0.25 0.47 0.07 0.15 0.28 80.4 137.7 222.1 6.4 10.1 15.7
Mean age, y 57.7 60.9 60.5 57.6 59.5 62.2 60 59.9 58.5 56.9 59.2 63.2†
Mean BMI, kg/m2 27.3 27.5 26.3 26.2 28.2 26.6 25.8 27.8 28.8† 26.8 27.9 26.3
Female, % 25.6 25.6 13.9 23.3 22.7 18.6 21.6 17.3 25.5 16.3 29.5 18.6
Stage III or IV, % 90.7 74.4 81.4 95.3 77.3 74.4† 84.3 82.7 82.3 86 77.3 83.7
Current smokers, % 62.3 32.6 16.3‡ 60.5 36.4 13.9‡ 47.1 32.7 31.4 18.6 15.9 27.9
No comorbidities, % 20.9 23.3 34.9 20.9 27.3 30.2 21.6 26.9 31.4 23.3 25 30.2
Leafy green vegetables, servings/d 0.36 0.32 0.46 0.28 0.36 0.51† 0.32 0.35 0.44 0.33 0.46 0.36
Cruciferous vegetables, servings/d 0.26 0.20 0.28 0.16 0.24 0.21 0.28 0.16 0.25 0.25 0.25 0.23
Dark yellow and orange vegetables, servings/d 0.16 0.18 0.37‡ 0.16 0.19 0.35‡ 0.26 0.18 0.23 0.21 0.23 0.26
Fruits, servings/d 0.80 0.94 1.21† 0.72 0.95 1.28‡ 0.91 0.87 1.02 0.78 1.21 0.95
Abbreviation: BMI, body mass index.
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included leafy green vegetables, dark-yellow and orange
vegetables, and fruit – all rich food sources of xantho-
phylls and total carotenoids. Therefore, it is less likely
that bias or confounding were responsible for these previ-
ously observed associations based on the reported diet.
Similar to our results, Sakhi et al6 found that higher
pretreatment serum carotenoids measured in 60 patients,
predicted better progression-free survival. However, other
studies suggest the relationship between head and neck
cancer mortality and carotenoids and tocopherols may be
modified by smoking status. As has been previously
reported, it is possible that carotenoids and tocopherols
have a detrimental effect, especially in smokers, when
consumed in high doses from supplements that are
unlikely to be attained through dietary intake alone.28,29
A randomized controlled trial carried out in a sample of
540 patients newly diagnosed with head and neck cancer
showed that smokers randomized to the a-tocopherol and
b-carotene supplementation group had increased recur-
rence, mortality, and second primary cancers compared to
nonsmokers and placebo.30 Interestingly, however, higher
reported b-carotene dietary intake (ie, not from supple-
ments) before randomization and subsequent radiotherapy
was associated with reduced risk of local recurrence,
regardless of smoking status.24 In another study, Mayne
et al3 reported protective effects of total serum carote-
noids on mortality, but increased mortality with higher
a-tocopherol in posttreatment of patients with head and
neck cancer who were smokers and disease-free at the
time of blood sampling. We did not have the statistical
power to assess effect modification by smoking status in
the current study, but this issue warrants further investiga-
tion in the future.
We found that xanthophylls were strongly associated
with better head and neck cancer outcomes. Consistent
with our findings, Hughes et al31 found that xanthophylls,
either individually or grouped, were inversely associated
with a urinary marker of oxidative stress. The xantho-
phylls include the oxygenated carotenoids lutein,
b-cryptoxanthin, and zeaxanthin. It is unclear if their pro-
tective effects in cells are the result of chemical or
biochemical properties of these carotenoids or of some
other aspect of foods that are high in xanthophylls.
Although a-carotenes and b-carotenes are distributed in a
wider variety of fruits and vegetables than the other caro-
tenoids measured, lutein and zeaxanthin are high mainly
in leafy green vegetables that are typically low in the
U.S. diet.32 Men tend to eat less fruit than women,33 and
b-cryptoxanthin is especially high in dark orange fruits.
More heterogeneity in dietary intakes and blood concen-
trations may be present for xanthophylls than the other
carotenoids because of their distribution in a smaller vari-
ety of fruits and vegetables. Few supplements containing
xanthophylls are currently available and so it is unknown
FIGURE 1. Kaplan–Meier plots for recurrence and survival from head and neck cancer by tertiles of serum micronutrient concentrations, given in
months from diagnosis. Xanthophylls were the sum of lutein, zeaxanthin, and b-cryptoxanthin. Total carotenoids were the sum of xanthophylls,
lycopene, a-carotene, and b-carotene. Total tocopherols were the sum of a-tocopherols and g-tocopherols.
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whether supplemental xanthophylls would behave the
same way as b-carotene and tocopherols and interact with
smoking and/or increase cancer risk and mortality.
Unlike carotenoids, higher quercetin concentrations were
not protective. Concentrations of quercetin, kaempferol, narin-
genin, and hesperitin in fasting plasma have been shown to be
reasonable biomarkers of recent dietary intakes with a short
half-life.34 Carotenoids are highly non-polar with much longer
half-lives.35–37 Quercetin is more polar and has both poor and
highly variable bioavailability.38 Therefore, the findings that
quercetin was not associated with survival may not negate the
potential protective effects of foods that contain quercetin.
The results of this study should be interpreted in light
of several strengths and limitations. Strengths include the
prospective study design, ability to adjust for some of the
most significant potential confounding factors, and the
ability to account for HPV status of the tumor. Numerous
studies have reported a survival advantage in patients
with head and neck cancer with HPV-positive tumors
compared to those with HPV-negative tumors.39 Our
group previously reported that HPV-positivity was associ-
ated with significantly higher intakes of chemoprotective
micronutrients.40 In the current study, we were able to
account for HPV status when adjusting for tumor site,
decreasing the potential for confounding by this charac-
teristic. Because of the small sample size and incomplete
data on posttreatment smoking status on 30.6% of the
study population, we did not have the statistical power to
consider tobacco use as a time-dependent variable in sta-
tistical models, which was a limitation. Another limitation
was that we did not have the power to evaluate patients
by type of cancer treatment received. In patients with
stage IV disease, which were the majority of the study
group, the efficacy of chemotherapy and radiation therapy
is variable. We also found significant, inverse correlations
between sample storage time and a-carotene, b-carotene,
and total carotenoids, suggesting there may have been
some degradation of these nutrients in the older serum
samples that were used in this analysis. However, we
hypothesize that any degradation of nutrients that may
have occurred in our samples over time likely resulted in
an attenuation of their associations with recurrence-free
and overall survival time. Finally, the prospective study
design only allowed for the determination of associations,
and we cannot rule out the possibility of reverse causality
and potential unmeasured and residual confounding.
In summary, we found strong protective associations of
serum xanthophyll and total carotenoid concentrations on
overall survival time and protective associations of serum
xanthophyll concentrations with recurrence-free time in
patients with head and neck cancer. This indicates that, in
this population, dietary intake of other micronutrients
with putative preventive properties was either already suf-
ficiently high for maximal benefit and/or that intake of
foods high in xanthophylls and carotenoids was deficient.
Future research could evaluate the possible benefits of an
intervention to increase intakes of foods that are rich
sources of xanthophylls in patients with head and neck
cancer or in persons at increased risk for head and neck
cancer.
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